Curcumin Bioavailability in Glioblastoma Patients
June 1, 2013 updated by: Stephan Dützmann, Johann Wolfgang Goethe University Hospital
Measurement of Intratumoral Concentration of the Nontoxic Natural Compound Curcumin in Glioblastoma Patients
Measuring the bioavailability of orally administered curcumin in the tumors of glioblastoma patients.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Anticipated)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hessen
-
Frankfurt, Hessen, Germany, 60528
- Department of Neurosurgery, Johann Wolfgang Goethe-University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients harboring Glioblastoma
Description
Inclusion Criteria:
- Patients harboring Glioblastoma
- Patient will undergo surgery
Exclusion Criteria:
- BMI > 30
- Liver and Kidney Function so compromised that medication is prescribed
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concentration of Curcumin in Glioblastoma
Time Frame: At Tumor resection
|
At the time of surgery
|
At Tumor resection
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Stephan Duetzmann, Goethe University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
October 20, 2012
First Submitted That Met QC Criteria
October 22, 2012
First Posted (Estimate)
October 23, 2012
Study Record Updates
Last Update Posted (Estimate)
June 4, 2013
Last Update Submitted That Met QC Criteria
June 1, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JohannWGUH_Curcumin-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Harboring Glioblastoma That Will Undergo Surgery
-
Steno Diabetes Center CopenhagenHvidovre University HospitalCompletedObese Subjects Who Will Undergo Gastric By-pass SurgeryDenmark
-
Dr Abdurrahman Yurtaslan Ankara Oncology Training...RecruitingFemale Patients Under the Age of 65 Who Will Undergo Breast Cancer SurgeryTurkey
-
Baskent UniversityActive, not recruitingoPAP Should be > 25mmHg in Right Heart Catheterization at Rest | There Should be Patients Who Will Undergo Non-cardiac and Non-obstetric SurgeryTurkey